Weiner P, Zamir D, Waizman J, Weiner M
Dept. of Medicine A, Hillel Yaffe Medical Center, Hadera.
Harefuah. 1996 Jul;131(1-2):14-7, 71.
Chronic obstructive pulmonary disease (COPD) is characterized by sputum production and cough. It has been shown that mucus hypersecretion predisposes to recurrent bronchial infection and that reduction in airway secretions is associated with clinical improvement. Recently a new pipe-shaped device for chest physiotherapy, the flutter VRP1 ("VarioRaw:" Aubonne, Switzerland), was introduced in order to help clear bronchial hypersecretion. We determined the long-term efficacy of daily chest physiotherapy with the VRP1 in COPD and bronchial hypersecretion. 13 men and 7 women with COPD and sputum hypersecretion were studied; 10 were assigned to the physiotherapy group, and 10 to the control group getting sham therapy. After 3 months of physiotherapy, FVC, FEV1 and distance walked in 12 minutes increased in the treated group, but were almost unchanged in the sham-treated group. Arterial blood gases, the maximum voluntary ventilation, and respiratory rate at rest were unchanged in both groups. There was also an overall significant improvement in COPD symptoms in the physiotherapy group compared to baseline (p < 0.05). We conclude that long-term home physiotherapy with the flutter VRP1 is effective in COPD in improving airflow, functional ability and symptoms.
慢性阻塞性肺疾病(COPD)的特征是咳痰和咳嗽。研究表明,黏液分泌过多易导致反复支气管感染,而气道分泌物减少与临床症状改善相关。最近,一种用于胸部物理治疗的新型管状装置——颤动VRP1(“VarioRaw”:瑞士奥博讷)被引入,以帮助清除支气管分泌过多的黏液。我们确定了每日使用VRP1进行胸部物理治疗对COPD和支气管分泌过多的长期疗效。研究了13名男性和7名患有COPD且痰液分泌过多的女性;10人被分配到物理治疗组,10人被分配到接受假治疗的对照组。经过3个月的物理治疗,治疗组的用力肺活量(FVC)、第1秒用力呼气容积(FEV1)和12分钟步行距离增加,而假治疗组几乎没有变化。两组的动脉血气、最大自主通气量和静息呼吸频率均未改变。与基线相比,物理治疗组的COPD症状也有总体显著改善(p < 0.05)。我们得出结论,长期在家使用颤动VRP1进行物理治疗对COPD患者改善气流、功能能力和症状有效。